alexa Retargeting Of HIV Reverse Transcriptase To MHC Class II Processing Improves Its Immunogenicity
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Vaccines & Vaccination
September 24-26, 2014 Valencia Convention Centre, Spain

Latanova Anastasia, Starodubova E, Petkov S, Kuzmenko Y, Krotova O, Isaguliants M and Karpov V
Posters: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.021
C urrently tested multi-gene DNA vaccines towards HIV fail to induce a strong immune response against reverse transcriptase (RT) which is a key enzyme in the viral escape from drugs. Design of DNA-vaccine against HIV, specifically against drug resistant virus variants, requests a considerable enhancement of RT-specific immune response. MHC class II targeting of RT by fusion with signals of lysosome targeting of lysosome-associated membrane protein I, fragment of invariant chain and the minimal Gly-Ala repeat of EBNA1 tested previously somewhat improved the cellular, but not the humoral immune response to RT. To further strengthen its immunogenic performance, we N-terminally fused RT to the leader sequence of nonstructural protein 1 (NS1) of TBE. The NS1-RT chimera was detected both on the surface of transfected cells and in the cell culture medium. BALB/c mice were immunized with RT gene chimera by intradermal injection followed by electroporation, and immune response was assessed by serology, IFN-g/IL-2 Fluorospot, ICCS for IFN-g, IL-2; and ELISA for perforin and granzyme B. NS1-RT chimeric gene induced a potent Th2-tilted immune response manifested by strong dual IFN-gamma/ IL-2 production and secretion of perforin and granzyme B by murine splenocytes stimulated with RT-peptides. Moreover, mice response by high anti-RT antibody production reaching 80000 for IgG and 1000 for systemic IgA. Thus retargeting of RT processing and presentation by turning it into secretable protein resulted in strong potentiation of RT-specific immune response.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version